These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Potential of gene therapy as a treatment for heart failure. Hajjar RJ J Clin Invest; 2013 Jan; 123(1):53-61. PubMed ID: 23281410 [TBL] [Abstract][Full Text] [Related]
4. Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases. Lipskaia L; Hadri L; Lopez JJ; Hajjar RJ; Bobe R Curr Vasc Pharmacol; 2013 Jul; 11(4):465-79. PubMed ID: 23905641 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for heart failure: where do we stand? Naim C; Yerevanian A; Hajjar RJ Curr Cardiol Rep; 2013 Feb; 15(2):333. PubMed ID: 23307169 [TBL] [Abstract][Full Text] [Related]
6. Rescuing the failing heart by targeted gene transfer. Kawase Y; Ladage D; Hajjar RJ J Am Coll Cardiol; 2011 Mar; 57(10):1169-80. PubMed ID: 21371634 [TBL] [Abstract][Full Text] [Related]
15. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure. Papolos A; Frishman WH Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057 [TBL] [Abstract][Full Text] [Related]
16. Advances in gene therapy for heart failure. Fish KM; Ishikawa K Discov Med; 2015 Apr; 19(105):285-91. PubMed ID: 25977191 [TBL] [Abstract][Full Text] [Related]
17. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Zsebo K; Yaroshinsky A; Rudy JJ; Wagner K; Greenberg B; Jessup M; Hajjar RJ Circ Res; 2014 Jan; 114(1):101-8. PubMed ID: 24065463 [TBL] [Abstract][Full Text] [Related]
18. New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides. Zhai Y; Luo Y; Wu P; Li D J Med Genet; 2018 May; 55(5):287-296. PubMed ID: 29478009 [TBL] [Abstract][Full Text] [Related]
19. Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia. Xin W; Li X; Lu X; Niu K; Cai J Acta Cardiol; 2011 Feb; 66(1):57-64. PubMed ID: 21446381 [TBL] [Abstract][Full Text] [Related]
20. Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy. Samuel TJ; Rosenberry RP; Lee S; Pan Z Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]